A significant proportion of patients with primary central nervous system lymphoma harbor clonal bone marrow B-cells

References

• Hoang-Xuan K, Bessell E, Bromberg J, et al. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncol. 2015;16:e322–e332.
   PubMed Web of Science ®Google Scholar
• Schmitz N, Wu HS. Advances in the Treatment of Secondary CNS Lymphoma. Jco. 2015; Nov 2033:3851–3853.
   PubMed Web of Science ®Google Scholar
• Ferreri AJ, Donadoni G, Cabras MG, et al. High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial. Jco. 2015;33:3903–3910.
   PubMed Web of Science ®Google Scholar
• Randen U, Tierens AM, Tjonnfjord GE, et al. Bone marrow histology in monoclonal B-cell lymphocytosis shows various B-cell infiltration patterns. Am J Clin Pathol. 2013;139:390–395.
   PubMed Web of Science ®Google Scholar
• Nelson BP, Abdul-Nabi A, Goolsby C, et al. Characterization of tissue findings in bone marrow biopsy specimens with small monoclonal B-cell populations. Am J Clin Pathol. 2014;141:687–696.
   PubMed Web of Science ®Google Scholar
• Shim YK, Middleton DC, Caporaso NE, et al. Prevalence of monoclonal B-cell lymphocytosis: a systematic review. Cytometry. 2010;78B:S10–S18.
   Google Scholar
• van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257–2317.
   PubMed Web of Science ®Google Scholar
• Schliffke S, Akyuz N, Ford CT, et al. Clinical response to ibrutinib is accompanied by normalization of the T-cell environment in CLL-related autoimmune cytopenia. Leukemia. 2016;30:2232–2234.
   PubMed Web of Science ®Google Scholar
• Oberle A, Brandt A, Voigtlaender M, et al. Monitoring multiple myeloma by next-generation sequencing of V(D)J rearrangements from circulating myeloma cells and cell-free myeloma DNA. Haematologica. 2017;102:1105–1111.
   PubMed Web of Science ®Google Scholar
• Schliffke SSM, Kim E, von Wenserski L, et al. Dynamic changes of the normal B lymphocyte repertoire in chronic lymphocytic leukemia in response to ibrutinib or FCR chemo-immunotherapy. Oncoimmunology. 2018;7:e1417720.
   PubMed Web of Science ®Google Scholar
• Bolotin DA, Poslavsky S, Mitrophanov I, et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat Methods. 2015;12:380–381.
   PubMed Web of Science ®Google Scholar
• Fritsch K, Kasenda B, Schorb E, et al. High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study). Leukemia 2017;31:846–852.
   PubMed Web of Science ®Google Scholar
• Ferreri AJ, Cwynarski K, Pulczynski E, et al. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Lancet Haematol. 2016;3:e217–e227.
   PubMed Web of Science ®Google Scholar
• Illerhaus G, Kasenda B, Ihorst G, et al. High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial. Lancet Haematol. 2016;3:e388–e397.
   PubMed Web of Science ®Google Scholar
• Voigtlaender M, Vogler B, Trepel M, et al. Hospital population screening reveals overrepresentation of CD5(-) monoclonal B-cell lymphocytosis and monoclonal gammopathy of undetermined significance of IgM type. Ann Hematol. 2015;94:1559–1565.
   PubMed Web of Science ®Google Scholar
• Nieto WG, Almeida J, Romero A, et al. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. Blood. 2009;114:33–37.
   PubMed Web of Science ®Google Scholar
• Dagklis A, Fazi C, Sala C, et al. The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring. Blood. 2009;114:26–32.
   PubMed Web of Science ®Google Scholar
• Shanafelt TD, Ghia P, Lanasa MC, et al. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia. 2010;24:512–520.
   PubMed Web of Science ®Google Scholar
• Rossi D, Sozzi E, Puma A, et al. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Br J Haematol. 2009;146:64–75.
   PubMed Web of Science ®Google Scholar
• Tierens AM, Holte H, Warsame A, et al. Low levels of monoclonal small B cells in the bone marrow of patients with diffuse large B-cell lymphoma of activated B-cell type but not of germinal center B-cell type. Haematologica. 2010;95:1334–1341.
   PubMed Web of Science ®Google Scholar
• Malecka A, Tierens A, Ostlie I, et al. Primary diffuse large B-cell lymphoma associated with clonally-related monoclonal B lymphocytosis indicates a common precursor cell. Haematologica. 2015;100:e415–e418.
   PubMed Web of Science ®Google Scholar
• Jahnke K, Hummel M, Korfel A, et al. Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes. Jco. 2006;24:4754–4757.
   PubMed Web of Science ®Google Scholar
• McCann KJ, Ashton-Key M, Smith K, et al. Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development. Blood. 2009;113:4677–4680.
   PubMed Web of Science ®Google Scholar
• Jahnke K, Thiel E, Martus P, et al. Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors. J Neurooncol. 2006;80:159.
   PubMed Web of Science ®Google Scholar
• Abrey LE, DeAngelis LM, Yahalom J. Long-term survival in primary CNS lymphoma. Jco. 1998;16:859–863.
   PubMed Web of Science ®Google Scholar